GGrantIndex
← Leaderboards

Christopher Broder

Henry M. Jackson Fdn For The Adv Mil/Med

Google Scholar ↗PubMed ↗ORCID ↗
$27,231,881
Attributed
$27,444,163
Total exposure
15
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $51M · FY2005–24
$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$98,450,019 · 17

By mechanism

U19$82,193,270 · 6
U01$7,782,678 · 2
R01$4,901,169 · 2
U54$1,993,053 · 2
R21$1,579,849 · 4
P01$0 · 1

Top collaborators

Most similar at Henry M. Jackson Fdn For The Adv Mil/Med

Same institution · by research overlap

Others in their field

Top investigators on “Henipavirus”

Research focus

HenipavirusVirusNipah VirusHendra VirusTropismViralAnimalsNeutralizing AntibodyGlycoprotein GInfectionParamyxovirusGlycoproteinsCellsVaccinesAustraliaLivestockRna VirusesVirus DiseasesCollaborationsTransmission ProcessReceptorPersonsNervous System DisorderBangladesh

Grant awards (59)

Paramyxoviridae and Bunyavirales Vaccines and Antibodies Center (PABVAX)$46,404,982
U19 · FY2024 · AI
RP2: Vaccines and antibodies to henipavirus$4,640,498
U19 · FY2024 · AI · contact PI
Advancement of Vaccines and Therapies for Henipaviruses$5,631,841
U19 · FY2023 · AI · contact PI
Project 3 - USUHS$632,744
U19 · FY2023 · AI · contact PI
Core A - Administrative Core$252,377
U19 · FY2023 · AI · contact PI
Project-004$140,636
U19 · FY2023 · AI · contact PI
Advancement of Vaccines and Therapies for Henipaviruses$5,616,110
U19 · FY2022 · AI · contact PI
Core A - Administrative Core$802,303
U19 · FY2022 · AI · contact PI
Project-004$802,301
U19 · FY2022 · AI · contact PI
Project 3 - USUHS$802,301
U19 · FY2022 · AI · contact PI
Advancement of Vaccines and Therapies for Henipaviruses$4,765,823
U19 · FY2021 · AI · contact PI
Project 3 - USUHS$911,234
U19 · FY2021 · AI · contact PI
Core A - Administrative Core$171,964
U19 · FY2021 · AI · contact PI
Advancement of Vaccines and Therapies for Henipaviruses$4,326,275
U19 · FY2020 · AI · contact PI
Project 3 - USUHS$808,881
U19 · FY2020 · AI · contact PI
Core A - Administrative Core$163,035
U19 · FY2020 · AI · contact PI
Advancement of Vaccines and Therapies for Henipaviruses$4,260,825
U19 · FY2019 · AI · contact PI
Project 3 - USUHS$849,192
U19 · FY2019 · AI · contact PI
Core A - Administrative Core$209,948
U19 · FY2019 · AI · contact PI
A Recombinant Cedar Virus-based Henipavirus Replication Platform for High-throughput Inhibitor Screening$193,928
R21 · FY2019 · AI · contact PI
A Recombinant Cedar Virus-based Henipavirus Replication Platform for High-throughput Inhibitor Screening$230,636
R21 · FY2018 · AI · contact PI
Henipavirus Entry and Virion Assembly$377,783
R01 · FY2016 · AI · contact PI
Henipavirus Entry and Virion Assembly$377,783
R01 · FY2015 · AI · contact PI
Henipavirus Entry and Virion Assembly$377,783
R01 · FY2014 · AI · contact PI
Henipavirus Entry and Virion Assembly$355,116
R01 · FY2013 · AI · contact PI
Australian bat lyssavirus tropism entry and host factor dependence$299,599
U54 · FY2013 · AI · contact PI
Vaccines and Therapeutics for Nipah and Hendra virus$1,072,517
U01 · FY2012 · AI · contact PI
Australian bat lyssavirus tropism entry and host factor dependence$346,316
U54 · FY2012 · AI · contact PI
Vaccines and Therapeutics for Nipah and Hendra virus$1,067,628
U01 · FY2011 · AI · contact PI
Australian bat lyssavirus tropism entry and host factor dependence$349,396
U54 · FY2011 · AI · contact PI
Vaccines and Therapeutics for Nipah and Hendra virus$1,146,198
U01 · FY2010 · AI · contact PI
Australian bat lyssavirus tropism entry and host factor dependence$355,460
U54 · FY2010 · AI · contact PI
Nipah Virus and Hendra Virus Entry and Virion Assembly$312,825
R01 · FY2010 · AI · contact PI
Vaccines and Therapeutics for Nipah and Hendra virus$1,075,508
U01 · FY2009 · AI · contact PI
Australian bat lyssavirus tropism entry and host factor dependence$342,198
U54 · FY2009 · AI · contact PI
Nipah Virus and Hendra Virus Entry and Virion Assembly$306,780
R01 · FY2009 · AI · contact PI
Vaccines and Therapeutics for Nipah and Hendra virus$1,153,911
U01 · FY2008 · AI · contact PI
Emerging Viruses$300,084
U54 · FY2008 · AI · contact PI
Nipah Virus and Hendra Virus Entry and Virion Assembly$297,846
R01 · FY2008 · AI · contact PI
HIV-1 Fusion Coreceptors$281,840
R01 · FY2008 · AI · contact PI
Nipah Virus and Hendra Virus Entry and Virion Assembly$399,990
R01 · FY2007 · AI · contact PI
HIV-1 Fusion Coreceptors$287,299
R01 · FY2007 · AI · contact PI
Nipah virus and Hendra virus Peptide Therapeutics$644,416
U01 · FY2006 · AI · contact PI
Nipah Virus and Hendra Virus Entry and Virion Assembly$311,039
R01 · FY2006 · AI · contact PI
HIV-1 Fusion Coreceptors$295,880
R01 · FY2006 · AI · contact PI
Nipah Virus and Hendra Virus Subunit Vaccines$221,910
R21 · FY2006 · AI · contact PI
Nipah virus and Hendra virus Peptide Therapeutics$687,159
U01 · FY2005 · AI
HIV-1 Fusion Coreceptors$257,550
R01 · FY2005 · AI
Nipah Virus and Hendra Virus Subunit Vaccines$189,375
R21 · FY2005 · AI
Nipah virus and Hendra virus Peptide Therapeutics$607,239
U01 · FY2004 · AI
Nipah virus and Hendra virus Peptide Therapeutics$328,102
U01 · FY2003 · AI
HIV-1 Fusion Coreceptors$299,400
R21 · FY2003 · AI
HIV-1 FUSION COFACTORS$227,102
R01 · FY2002 · AI
HIV-1 gp140 Oligomers as Vaccine Immunogens$0
P01 · FY2002 · AI
HIV-1 ENVELOPE-CD4-CORECEPTOR COMPLEXES AS VACCINES$222,300
R21 · FY2001 · AI
HIV-1 FUSION COFACTORS$220,487
R01 · FY2001 · AI
HIV-1 gp140 Oligomers as Vaccine Immunogens$0
P01 · FY2001 · AI
HIV-1 ENVELOPE-CD4-CORECEPTOR COMPLEXES AS VACCINES$222,300
R21 · FY2000 · AI
HIV-1 FUSION COFACTORS$214,066
R01 · FY2000 · AI